1. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019) Authors: Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic... Journal: Lancet Issue: Volume 394:Issue 10212(2019) Page Start: 1929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019) Authors: Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic... Journal: Lancet Issue: Volume 394:Issue 10212(2019) Page Start: 1929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. Issue 1 (January 2021) Authors: Goldman, Jonathan W; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Garassino, Marina Chiara; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libo... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022) Authors: Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian; Abdulkhakov, Rustem; Abu ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 1(2022) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial. Issue 10063 (17th December 2016) Authors: Robertson, John F R; Bondarenko, Igor M; Trishkina, Ekaterina; Dvorkin, Mikhail; Panasci, Lawrence; Manikhas, Alexey; Shparyk, Yaroslav; Cardona-Huerta, Servando; Cheung, Kwok-Leung; Philco-Salas, Manuel Jesus; Ruiz-Borrego, Manuel; Shao, Zhimin; Noguchi, Shinzaburo; Rowbottom, Jacqui; Stuart, Ma... Journal: Lancet Issue: Volume 388:Issue 10063(2016) Page Start: 2997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design. (31st October 2018) Authors: Moehler, Markus; Ryu, Min-Hee; Dvorkin, Mikhail; Lee, Keun-Wook; Coşkun, Hasan Ş; Wong, Rachel; Chung, Hyun C; Poltoratsky, Artem; Tsuji, Akihito; Yen, Chia Jui; Muntean, Alina S; Le Sourd, Samuel; Vaccaro, Gina M; Overton, Lindsay; Boku, Narikazu; Wainberg, Zev A; Patel, Manish; Sharma, Maitreyi... Journal: Future oncology Issue: Volume 15:Number 6(2019) Page Start: 567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study. (November 2020) Authors: Goldman, Jonathan W.; Garassino, Marina Chiara; Chen, Yuanbin; Özgüroğlu, Mustafa; Dvorkin, Mikhail; Trukhin, Dmytro; Statsenko, Galina; Hotta, Katsuyuki; Ji, Jun Ho; Hochmair, Maximilian J.; Voitko, Oleksandr; Havel, Libor; Poltoratskiy, Artem; Losonczy, György; Reinmuth, Niels; Patel, Nikunj; L... Journal: Lung cancer Issue: Volume 149(2020) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100. Issue 9 (20th March 2021) Authors: Moehler, Markus; Dvorkin, Mikhail; Boku, Narikazu; Özgüroğlu, Mustafa; Ryu, Min-Hee; Muntean, Alina S.; Lonardi, Sara; Nechaeva, Marina; Bragagnoli, Arinilda C.; Coşkun, Hasan S.; Cubillo Gracian, Antonio; Takano, Toshimi; Wong, Rachel; Safran, Howard; Vaccaro, Gina M.; Wainberg, Zev A.; Silver, ... Journal: Journal of clinical oncology Issue: Volume 39:Issue 9(2021) Page Start: 966 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer. (April 2022) Authors: Edelman, Martin J.; Dvorkin, Mikhail; Laktionov, Konstatin; Navarro, Alejandro; Juan-Vidal, Oscar; Kozlov, Vadim; Golden, Gil; Jordan, Odette; Deng, CQ; Bentsion, Dmitriy; Chouaid, Christos; Dechev, Hristo; Dowlati, Afshin; Fernández Núñez, Natalia; Ivashchuk, Olexandr; Kiladze, Ivane; Kortua, Ts... Journal: Lung cancer Issue: Volume 166(2022) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial. Issue 4 (April 2022) Authors: Kristeleit, Rebecca; Lisyanskaya, Alla; Fedenko, Alexander; Dvorkin, Mikhail; de Melo, Andreia Cristina; Shparyk, Yaroslav; Rakhmatullina, Irina; Bondarenko, Igor; Colombo, Nicoletta; Svintsitskiy, Valentyn; Biela, Luciano; Nechaeva, Marina; Lorusso, Domenica; Scambia, Giovanni; Cibula, David; Pó... Journal: Lancet oncology Issue: Volume 23:Issue 4(2022) Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗